glp 1 and basal insulin Beyond Insulin: How Glucagon-Like Peptide-1 Receptor Agonists Fit in the Spectrum of Therapeutic Options Fixed Ratio Combination Overview -

& Ferns, G

Patients were to be randomized to 1200 mg, 450 mg, or placebo, administered intravenously daily for 3 days followed by weekly for 4 weeks

Products labeled "GLP-1" in retail stores or online are herbal supplements containing no GLP-1 medication

McCarty D, Olenik A, McCarty BP (2019) Efficacy and safety of basal insulin/GLP-1 receptor agonist used in combination for type 2 diabetes management

Featured Clinical Resources Featured Charts and Graphics CHART: Meds That Should Not Be Crushed CHART: Comparison of Weight Loss Products Flu Vaccines for 2025-26 (US) CHART: FAQ: Communicating About Flu Vaccination CHART: COVID-19 Vaccines 2025-26 (US) ALGORITHM: Meningococcal Vaccination FAQ: Med Considerations for Cats & Dogs CHART: Smoking Cessation Drug Therapy

One of the most recent contributions came from researchers at Thomas Jefferson University in Philadelphia, who in 2016 published a relevant study in the journal PLoS One